NAVAMEDIC (NAVA.OL) Stock Price & Overview
OSL:NAVA • NO0010205966
Current stock price
The current stock price of NAVA.OL is 19.95 NOK. Today NAVA.OL is up by 1.53%. In the past month the price decreased by -6.78%. In the past year, price decreased by -8.49%.
NAVA.OL Key Statistics
- Market Cap
- 478.401M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.11
- Dividend Yield
- N/A
NAVA.OL Stock Performance
NAVA.OL Stock Chart
NAVA.OL Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NAVA.OL. When comparing the yearly performance of all stocks, NAVA.OL is a bad performer in the overall market: 78.81% of all stocks are doing better.
NAVA.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NAVA.OL. NAVA.OL may be in some trouble as it scores bad on both profitability and health.
NAVA.OL Earnings
NAVA.OL Forecast & Estimates
7 analysts have analysed NAVA.OL and the average price target is 36.72 NOK. This implies a price increase of 84.06% is expected in the next year compared to the current price of 19.95.
For the next year, analysts expect an EPS growth of 31.75% and a revenue growth 21.15% for NAVA.OL
NAVA.OL Groups
Sector & Classification
NAVA.OL Financial Highlights
Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of -1.11. The EPS decreased by -214.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.17% | ||
| ROE | -7.05% | ||
| Debt/Equity | 0.52 |
NAVA.OL Ownership
NAVA.OL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SNW | SANOFI | 9.42 | 187.917B | ||
| SAN | SANOFI | 9.44 | 187.821B | ||
| 1SAN | SANOFI | 9.08 | 185.84B | ||
| 1MRK | MERCK KGAA | 13.45 | 48.348B | ||
| UNC | UCB SA | 24.79 | 48.18B | ||
| UCB | UCB SA | 24.68 | 48.122B | ||
| MRK | MERCK KGAA | 12.84 | 44.935B | ||
| 1BAYN | BAYER AG-REG | 8.19 | 37.671B | ||
| BAYN | BAYER AG-REG | 8.15 | 37.077B | ||
| IPN | IPSEN | 12.45 | 12.488B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.15 | 9.524B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.303B | ||
| VIRP | VIRBAC SA | 16.46 | 2.928B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About NAVA.OL
Company Profile
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Company Info
IPO: 2006-03-31
NAVAMEDIC
Henrik Ibsens gate 100
Oslo OSLO NO
Employees: 45
Phone: 4767112540
NAVAMEDIC / NAVA.OL FAQ
Can you describe the business of NAVAMEDIC?
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Can you provide the latest stock price for NAVAMEDIC?
The current stock price of NAVA.OL is 19.95 NOK. The price increased by 1.53% in the last trading session.
Does NAVA stock pay dividends?
NAVA.OL does not pay a dividend.
What is the ChartMill rating of NAVAMEDIC stock?
NAVA.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How many employees does NAVAMEDIC have?
NAVAMEDIC (NAVA.OL) currently has 45 employees.
What is NAVAMEDIC worth?
NAVAMEDIC (NAVA.OL) has a market capitalization of 478.40M NOK. This makes NAVA.OL a Small Cap stock.